profit from every $100 of sales.
$0$100
Clover Health Investments
$4.96+1.64% today
+100.8% in 1 year
1-year low $1.701-year high $5.41
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Clover Health Investments sold, what it kept, and what it did with the cash.
Sales went from $1.10 billion in 2022 to $1.92 billion in 2025, with -$85.5 million of profit last year.
SalesProfit
Clover Health Investments vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Clover Health Investments | No profit yet | ||
 Centene | No profit yet | ||
 Alignment Healthcare | No profit yet | ||
 Caring Brands | No profit yet | ||
 Basel Medical Group Ltd Ordinary Shares | No profit yet |
AI analysis
An AI analyst reads Clover Health Investments's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1,097 | 1,261 | 1,371 | 1,924 | |
| 103 | 256 | 365 | 356 | |
| -287 | -180 | -45 | -86 | |
| -252 | -208 | -45 | -84 | |
| -340 | -213 | -43 | -86 | |
| -0.71 | -0.44 | -0.08 | -0.17 | |
| 9.4% | 20.3% | 26.6% | 18.5% | |
| -26.1% | -14.2% | -3.3% | -4.4% | |
| -31.0% | -16.9% | -3.1% | -4.4% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 809 | 571 | 581 | 541 |
| Cash | 104 | 116 | 195 | 78 |
| Total debt | 6 | 5 | – | – |
| Total liabilities | 452 | 284 | 240 | 232 |
| 357 | 286 | 341 | 309 | |
| 476 | 482 | 490 | 512 | |
| -55.1% | -57.0% | -10.7% | -21.9% | |
| -95.1% | -74.5% | -12.6% | -27.7% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -204 | -145 | 35 | -67 | |
| 4 | 1 | 2 | 2 | |
| -208 | -145 | 33 | -69 | |
| Dividends paid | – | – | – | – |
| 6 | 6 | 18 | 55 | |
| 164 | 141 | 114 | 104 |
Valuation
- –
- 115.8×
- –
- 5.1×
- 1.4×
- –
- –
- -2.6%
- -3.2%
- 0.0%
Profitability
- 18.5%
- -4.4%
- -4.4%
- -2.5%
- -17.1%
- -62.3%
- -17.1%
- -8.2%
- -17.1%
- –
Growth
- +20.6%
- –
- −307.2%
- –
- +2.4%
Financial health
- -0.9×
- 0.00
- 0.0%
- –
- 1.33
- 1.33
- 3.16
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 23%of 946
Bottom 17%of 871
Top 28%of 867
Bottom 28%of 986
What analysts expect
- Average price target
- $3.33
- Range
- $1.80 – $6.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 6, 2026 | 0.07 | 0.07 | +0.0% |
| Feb 26, 2026 | -0.05 | -0.10 | +51.0% |
| Nov 4, 2025 | -0.05 | 0.02 | −350.0% |
| Aug 5, 2025 | 0.03 | 0.03 | +0.0% |
| May 6, 2025 | 0.05 | -0.07 | +171.4% |
| Feb 27, 2025 | -0.04 | -0.07 | +42.9% |
| Nov 6, 2024 | -0.02 | -0.01 | −50.0% |
| Aug 5, 2024 | 0.01 | -0.05 | +120.0% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
27No pass
Benjamin Graham
27No pass
Philip Fisher
40No pass
Peter Lynch
65Pass
Joel Greenblatt
0No pass
Charlie Munger
28No pass
Terry Smith
29No pass
Questions about Clover Health Investments
Is Clover Health Investments a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Clover Health Investments AI analysis
What does Clover Health Investments do?
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. It is in Medical - Healthcare Plans.
Does Clover Health Investments pay a dividend?
No. Clover Health Investments does not pay a dividend at the moment; in 2025 it returned $55.2 million to shareholders by buying back its own shares.
Is Clover Health Investments stock halal?
No. Clover Health Investments does not pass our halal screen: its main business, conventional insurance, is not permitted. How we check
How has Clover Health Investments stock done over the past year?
Up 100.8% over the past twelve months, to $4.96. It traded between $1.70 and $5.41 and is 8.3% below its high.
Who are Clover Health Investments's competitors?
The largest listed companies in the same industry are Centene, Alignment Healthcare, Caring Brands and Basel Medical Group Ltd Ordinary Shares. The peers table on this page compares their profit, growth and price with Clover Health Investments's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.